Immunodiagnostics Market Size

Immunodiagnostics Market size was valued at USD 24.17 Billion in 2023 and is poised to grow from USD 25.19 Billion in 2024 to USD 35.01 Billion by 2032, growing at a CAGR of 4.20% during the forecast period (2025-2032).

Growing incidence of chronic, infectious, and autoimmune diseases around the world is projected to primarily augment the demand for immunodiagnostics over the coming years. High emphasis on improving diagnostic capabilities and surging demand for early diagnosis are also expected to offer new business scope for immunodiagnostics providers in the future. Advancements in diagnostics technologies and rapidly rising demand for personalized medicine are also slated to increase the demand for immunodiagnostics over the coming years. High adoption of home healthcare and rising use of remote healthcare practices are expected to bolster the demand for home-based immunodiagnostics going forward. Rising healthcare expenditure and increasing geriatric population are also slated to create new opportunities for immunodiagnostics providers in the long run. On the contrary, inconsistency in regulatory norms and reimbursement policies, dearth of skilled professionals, high complexity of diagnostic procedures, and risk of false positives are estimated to be key restraints for immunodiagnostics market growth across the study period. 

US Immunodiagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.